Zhejiang Haichang Biotechnology Co., Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zhejiang Haichang Biotechnology Co., Ltd.
China mRNA COVID Vaccines Progress As Shanghai Rolls Out First Inhaled Shot
CanSino’s global-first inhaled COVID-19 vaccine is dosed into its first noses in Shanghai, while Zhejiang Haichang, Everest Medicines and Abogen make major progress with their respective mRNA vaccine programs.
TheOTCLab Launches World’s First Fungal Nail Plaster
Dutch foot-care specialists TheOTCLab launches what it claims to be the world's first fungal nail plaster.
Can You Kick It? Yes You Can, With Six New Foot-Care Products In The UK
New OTC medicines for fungal nail infections and verrucas have been launched in the UK by Galderma, Reckitt Benckiser and Vemedia, while new foot-care products have also been introduced by Blistex, Epitact and Dermatonics.
France's Supplement Market in 2018: Demand For Probiotics and Natural Alternatives Drives Sales Growth
France's food supplements market enjoyed broad-based growth across key categories in 2018, driven by consumer demand for natural alternatives to conventional medicine. Over the 12 months, Pileje overtook Arkopharma as the dominant player in market, as its leading probiotics brand, Symbiosys, flew off the shelves.
Company Information
- Industry
- Biotechnology
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice